{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:37:07Z","timestamp":1769553427438,"version":"3.49.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Desmopressin (<jats:sc>d<\/jats:sc>-amino<jats:sc>d<\/jats:sc>-arginine vasopressin: dDAVP) is used for the treatment of patients with hemophilia A and Von Willebrand disease. Studies on the rationale of dosing are scarce and mainly focus on the underlying causes of the vast differences in desmopressin response among individuals. The aim of this study was to develop and validate a liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS) method for the quantification of desmopressin in human plasma for identifying its pharmacokinetics and its therapeutic effect relationship in patients with bleeding disorder.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The method entails solid-phase extraction with ion exchange for sample clean-up, followed by an LC-MS\/MS run. The technique has been validated for analytical selectivity as well as specificity, process efficiency, linearity, accuracy, imprecision, and stability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>This method showed good selectivity because no significant chromatographic matrix interferences were observed. The determination coefficient (<jats:italic toggle=\"yes\">R<\/jats:italic><jats:sup>2<\/jats:sup>) of the calibration curves was \u22650.990. Analyte accuracy ranged from 89.2% to 111.8%, and the between- and within-run imprecision was less than 9.3% in a plasma concentration and range from 60 to 3200 pg\/mL. Samples were stable during 3 freeze\/thaw cycles with an additional 120 hours of storage at room temperature (21\u00b0C\u201324\u00b0C) and 96 hours in the autosampler (10\u00b0C). The total run time was approximately 5 minutes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>The LC-MS\/MS method presented enables quantification of desmopressin in human plasma, and it is sensitive, specific, efficient, accurate, and precise. This analytical technique is a valuable and useful tool to study the interpatient variability of pharmacokinetics.<\/jats:p><\/jats:sec>","DOI":"10.1097\/ftd.0000000000000791","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T05:02:36Z","timestamp":1595480556000},"page":"880-885","source":"Crossref","is-referenced-by-count":4,"title":["A Novel Quantitative Method for Analyzing Desmopressin in Human Plasma Using Liquid Chromatography\u2013Tandem Mass Spectrometry"],"prefix":"10.1097","volume":"42","author":[{"given":"Nico C. B.","family":"de Jager","sequence":"first","affiliation":[{"name":"Clinical Pharmacology and Hospital Pharmacy\u2014Amsterdam UMC, University of Amsterdam, Amsterdam;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Heijdra","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology, Erasmus University Medical Centre\u2014Sophia Children's Hospital, Rotterdam;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Pistorius","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Hospital Pharmacy\u2014Amsterdam UMC, University of Amsterdam, Amsterdam;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke J. H. A.","family":"Kruip","sequence":"additional","affiliation":[{"name":"Department of Haematology, Erasmus University Medical Centre, Rotterdam;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank W. G.","family":"Leebeek","sequence":"additional","affiliation":[{"name":"Department of Haematology, Erasmus University Medical Centre, Rotterdam;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjon H.","family":"Cnossen","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology, Erasmus University Medical Centre\u2014Sophia Children's Hospital, Rotterdam; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron A. A.","family":"Math\u00f4t","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Hospital Pharmacy\u2014Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/14656566.2018.1429406","article-title":"Desmopressin and nocturnal voiding dysfunction: clinical evidence and safety profile in the treatment of nocturia","volume":"19","author":"Chung","year":"2018","journal-title":"Expert Opin Pharmacother."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/hae.12732","article-title":"Side effects of desmopressin in patients with bleeding disorders","volume":"22","author":"Stoof","year":"2016","journal-title":"Haemophilia."},{"key":"R3-20230814","first-page":"775","article-title":"Side effects and complications of treatment with desmopressin for enuresis","volume":"86","author":"Robson","year":"1994","journal-title":"J Natl Med Assoc."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/hae.13451","article-title":"Analysis of current perioperative management with Haemate\u00ae P\/Humate P \u00ae in von Willebrand disease: identifying the need for personalized treatment","volume":"24","author":"Hazendonk","year":"2018","journal-title":"Haemophilia."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1182\/blood-2015-11-664680","article-title":"Rapid discrimination of the phenotypic variants of von Willebrand disease","volume":"127","author":"Roberts","year":"2016","journal-title":"Blood."},{"issue":"suppl 1","key":"R7-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2516.2007.01609.x","article-title":"Desmopressin: an historical introduction","volume":"14","author":"Mannucci","year":"2008","journal-title":"Haemophilia."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1182\/bloodadvances.2019000863","article-title":"Von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD","volume":"3","author":"Atiq","year":"2019","journal-title":"Blood Adv."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/joim.12645","article-title":"Vasopressin: physiology, assessment and osmosensation","volume":"282","author":"Bankir","year":"2017","journal-title":"J Intern Med."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00216-006-0581-4","article-title":"Validation and qualification: the fitness for purpose of mass spectrometry-based analytical methods and analytical systems","volume":"386","author":"Careri","year":"2006","journal-title":"Anal Bioanal Chem."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clinbiochem.2004.11.007","article-title":"Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry","volume":"38","author":"Taylor","year":"2005","journal-title":"Clin Biochem."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem."},{"key":"R17-20230814","article-title":"Population pharmacokinetic modelling of von Willebrand factor Activity in von Willebrand disease patients after desmopressin administration","author":"de Jager","year":"2020","journal-title":"Thromb Haemost."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(77)91197-7","article-title":"1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases","volume":"1","author":"Mannucci","year":"1977","journal-title":"Lancet."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10928-009-9133-9","article-title":"Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs","volume":"36","author":"Wolfsegger","year":"2009","journal-title":"J Pharmacokinet Pharmacodyn."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jpba.2004.02.009","article-title":"LC-MS determination of desmopressin acetate in human skin samples","volume":"35","author":"Getie","year":"2004","journal-title":"J Pharm Biomed Anal."},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.aca.2011.09.027","article-title":"Determination of vasopressin and desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes","volume":"707","author":"Thomas","year":"2011","journal-title":"Anal Chim Acta."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s00216-011-5697-5","article-title":"Qualitative detection of desmopressin in plasma by liquid chromatography-tandem mass spectrometry","volume":"402","author":"Esposito","year":"2012","journal-title":"Anal Bioanal Chem."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11094-011-0666-z","article-title":"Determination of desmopressin by HPLC-MS","volume":"45","author":"Nguyen","year":"2011","journal-title":"Pharm Chem J."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpha.2013.11.002","article-title":"Highly sensitive assay for the determination of therapeutic peptide desmopressin in human plasma by UPLC-MS\/MS","volume":"3","author":"Gudlawar","year":"2017","journal-title":"J Pharm Anal."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T17:57:50Z","timestamp":1696442270000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000791","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}